Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898853552> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2898853552 abstract "Background: Palmoplantar psoriasis (PPP) is a chronic, immune-mediated, inflammatory disorder affecting the palms and soles. Despite marked improvement in patient outcomes with use of biologic therapies, PPP remains hard to treat as the efficacy of systemic agents does not fully carry over to PPP trials. Methods: The study was approved by the institutional review board of Tufts Medical Center. It is a retrospective chart review of patients seen in Tufts Medical Center’s dermatology outpatient clinic who met the criteria of being diagnosed with PPP and received an anti-interleukin 17 A (IL-17A) concurrently with apremilast for a period of no less than 12 weeks. Four patients who met the criteria were included in the study, and descriptive analysis was performed due to the small sample size. Results: All 4 patients analyzed showed improvement in Palmoplantar Physician Global Assessment (PPPGA) while on combination apremilast and anti-IL17A therapy. Prior to anti-IL17A therapy, the first 3 patients had baseline PPPGAs of mild to severe. They then had PPPGAs of moderate while on anti-IL17A therapy and PPPGAs of clear/almost clear while on the combination of anti-IL17A therapy and apremilast. Patient 4 had a PPPGA of almost clear while on adalimumab, methotrexate, and acitretin and a PPPGA of clear after treatment with ixekizumab, apremilast, and methotrexate. Minimal side effects were reported on combination treatment. Conclusion: All 4 patients who were treated with combination anti-IL17A and apremilast achieved a PPPGA of clear or almost clear. Although the sample size is small, these encouraging results merit further investigation into combination therapy in the treatment of recalcitrant PPP." @default.
- W2898853552 created "2018-11-09" @default.
- W2898853552 creator A5001872149 @default.
- W2898853552 creator A5007369227 @default.
- W2898853552 creator A5008473117 @default.
- W2898853552 creator A5011324189 @default.
- W2898853552 creator A5027049119 @default.
- W2898853552 creator A5041061410 @default.
- W2898853552 creator A5049859852 @default.
- W2898853552 creator A5053003519 @default.
- W2898853552 creator A5059835508 @default.
- W2898853552 date "2018-10-01" @default.
- W2898853552 modified "2023-09-24" @default.
- W2898853552 title "Apremilast in Combination With an Interleukin 17A Inhibitor in the Treatment of Recalcitrant Palmoplantar Psoriasis" @default.
- W2898853552 cites W1778153929 @default.
- W2898853552 cites W1973354423 @default.
- W2898853552 cites W2007533329 @default.
- W2898853552 cites W2017932566 @default.
- W2898853552 cites W2157870332 @default.
- W2898853552 cites W2341637852 @default.
- W2898853552 cites W2527420241 @default.
- W2898853552 cites W2529389767 @default.
- W2898853552 cites W2766291043 @default.
- W2898853552 doi "https://doi.org/10.1177/2475530318788934" @default.
- W2898853552 hasPublicationYear "2018" @default.
- W2898853552 type Work @default.
- W2898853552 sameAs 2898853552 @default.
- W2898853552 citedByCount "5" @default.
- W2898853552 countsByYear W28988535522019 @default.
- W2898853552 countsByYear W28988535522020 @default.
- W2898853552 countsByYear W28988535522022 @default.
- W2898853552 crossrefType "journal-article" @default.
- W2898853552 hasAuthorship W2898853552A5001872149 @default.
- W2898853552 hasAuthorship W2898853552A5007369227 @default.
- W2898853552 hasAuthorship W2898853552A5008473117 @default.
- W2898853552 hasAuthorship W2898853552A5011324189 @default.
- W2898853552 hasAuthorship W2898853552A5027049119 @default.
- W2898853552 hasAuthorship W2898853552A5041061410 @default.
- W2898853552 hasAuthorship W2898853552A5049859852 @default.
- W2898853552 hasAuthorship W2898853552A5053003519 @default.
- W2898853552 hasAuthorship W2898853552A5059835508 @default.
- W2898853552 hasConcept C126322002 @default.
- W2898853552 hasConcept C16005928 @default.
- W2898853552 hasConcept C2776260265 @default.
- W2898853552 hasConcept C2776999253 @default.
- W2898853552 hasConcept C2778496887 @default.
- W2898853552 hasConcept C2779134260 @default.
- W2898853552 hasConcept C2780132546 @default.
- W2898853552 hasConcept C2780564577 @default.
- W2898853552 hasConcept C2781427535 @default.
- W2898853552 hasConcept C3020110884 @default.
- W2898853552 hasConcept C71924100 @default.
- W2898853552 hasConceptScore W2898853552C126322002 @default.
- W2898853552 hasConceptScore W2898853552C16005928 @default.
- W2898853552 hasConceptScore W2898853552C2776260265 @default.
- W2898853552 hasConceptScore W2898853552C2776999253 @default.
- W2898853552 hasConceptScore W2898853552C2778496887 @default.
- W2898853552 hasConceptScore W2898853552C2779134260 @default.
- W2898853552 hasConceptScore W2898853552C2780132546 @default.
- W2898853552 hasConceptScore W2898853552C2780564577 @default.
- W2898853552 hasConceptScore W2898853552C2781427535 @default.
- W2898853552 hasConceptScore W2898853552C3020110884 @default.
- W2898853552 hasConceptScore W2898853552C71924100 @default.
- W2898853552 hasLocation W28988535521 @default.
- W2898853552 hasOpenAccess W2898853552 @default.
- W2898853552 hasPrimaryLocation W28988535521 @default.
- W2898853552 hasRelatedWork W2766237518 @default.
- W2898853552 hasRelatedWork W2893942507 @default.
- W2898853552 hasRelatedWork W2898853552 @default.
- W2898853552 hasRelatedWork W2904182792 @default.
- W2898853552 hasRelatedWork W2911489527 @default.
- W2898853552 hasRelatedWork W2982146709 @default.
- W2898853552 hasRelatedWork W3195838575 @default.
- W2898853552 hasRelatedWork W3195950964 @default.
- W2898853552 hasRelatedWork W3212484138 @default.
- W2898853552 hasRelatedWork W653178933 @default.
- W2898853552 isParatext "false" @default.
- W2898853552 isRetracted "false" @default.
- W2898853552 magId "2898853552" @default.
- W2898853552 workType "article" @default.